This inventor holds 34 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Cancer Therapeutics. Top assignees: Vanderbilt University, Washington University, Arch Development Corporation. Active years: 1997-2022.
Location History:
- Des Plaines, IL (US) (2002)
- Chicago, IL (US) (1997 - 2006)
- Park Ridge, IL (US) (1997 - 2009)
- Nashville, TN (US) (2000 - 2014)
- St. Louis, MO (US) (2013 - 2022)
Company Filing History:
18 out of 1,218 
8 out of 1,376 
7 out of 349 
Years Active: 1997-2022
Areas of Expertise:
Title: Dennis E. Hallahan: Innovator in Cancer Therapy
Introduction
Dennis E. Hallahan is a prominent inventor based in Nashville, TN, recognized for his significant contributions to cancer research and therapy. With a remarkable portfolio of 34 patents, Hallahan has pioneered innovative approaches to tumor treatments, enhancing methods of drug delivery specific to cancer cells.
Latest Patents
Some of Hallahan's latest patents include "Antibodies to TIP1 and methods of use thereof," which disclose antigen binding proteins that aid in recognizing tumor cells and facilitate the targeted delivery of therapeutic drugs. Another notable recent invention is "Compositions targeting radiation-induced molecules and methods of use thereof," focusing on peptide constructs that bind to GRP78, thus benefiting treatments involving radiation therapy.
Career Highlights
Over the years, Hallahan has made significant strides in his field while working at esteemed institutions such as Vanderbilt University and Washington University. His extensive research endeavors have established him as a leader in creating innovative solutions for cancer treatment.
Collaborations
Throughout his career, Hallahan has collaborated with esteemed colleagues, including Ralph R. Weichselbaum and Donald W. Kufe. These partnerships have contributed to the advancement of his research, fostering an environment that encourages innovation and discovery in the realm of oncology.
Conclusion
Dennis E. Hallahan's work exemplifies the importance of innovation in medicine, particularly in the fight against cancer. With his numerous patents and collaborative efforts, he continues to shape the future of therapeutic strategies, aiming to improve patient outcomes and advance oncological science.